G1 Therapeutics (GTHX)
(Real Time Quote from BATS)
$7.08 USD
-0.01 (-0.14%)
Updated Aug 12, 2024 10:12 AM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | -0.12 |
EPS Last Quarter | -0.10 |
Last EPS Surprise | 41.18% |
ABR | 2.67 |
Earnings ESP
|
19.15% |
---|---|
Current Year | -0.46 |
Next Year | -0.14 |
EPS (TTM) | -0.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 17.14M | 22.92M | 70.73M | 86.11M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 18.27M | 31.71M | 80.19M | 97.95M |
Low Estimate | 15.72M | 16.21M | 62.95M | 67.90M |
Year ago Sales | 12.30M | 14.87M | 82.51M | 70.73M |
Year over Year Growth Est. | 39.35% | 54.12% | -14.28% | 21.75% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.12 | 0.02 | -0.46 | -0.14 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | -0.11 | -0.02 | -0.56 | -0.19 |
High Estimate | -0.06 | 0.21 | -0.30 | 0.01 |
Low Estimate | -0.17 | -0.11 | -0.59 | -0.65 |
Year ago EPS | -0.35 | -0.21 | -0.93 | -0.46 |
Year over Year Growth Est. | 65.71% | 109.52% | 50.54% | 70.43% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 3 | 2 | 2 |
Up Last 30 Days | 1 | 3 | 2 | 2 |
Up Last 60 Days | 2 | 4 | 4 | 4 |
Down Last 7 Days | 1 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.12 | 0.02 | -0.46 | -0.14 |
7 Days Ago | -0.13 | -0.02 | -0.50 | -0.22 |
30 Days Ago | -0.13 | -0.02 | -0.50 | -0.22 |
60 Days Ago | -0.14 | -0.06 | -0.54 | -0.34 |
90 Days Ago | -0.14 | -0.06 | -0.54 | -0.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | 0.03 | -0.48 | -0.02 |
Zacks Consensus Estimate | -0.12 | 0.02 | -0.46 | -0.14 |
Earnings ESP | 19.15% | 71.43% | -3.45% | 89.29% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.10 | -0.20 | -0.21 | -0.35 | NA |
Estimate | -0.17 | -0.19 | -0.27 | -0.31 | NA |
Difference | 0.07 | -0.01 | 0.06 | -0.04 | 0.02 |
Surprise | 41.18% | -5.26% | 22.22% | -12.90% | 11.31% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more